ArticleCells2025

MK2 Inhibition as a Novel Treatment for Fibrosis in Primary Sclerosing Cholangitis via an IL-22-Dependent Mechanism.

Cody S Howe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.